Analysts expect X4 Pharmaceuticals, Inc to report revenue of 2.43 M for Q3 26, against a range of 2.26 M to 2.61 M. The most recent reported quarter, Q2 26, came in at 8.81 M, a 256.9% beat against the 2.47 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 560,000.00 | 1.43 M | 28.81 M | 1.97 M | 1.76 M | 2.57 M | 2.71 M | 8.81 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.78 M | 1.13 M | 11.71 M | 1.76 M | 1.91 M | 1.82 M | 3.62 M | 2.70 M | 2.61 M | 2.34 M | 2.34 M | 2.94 M | 1.04 M | 1.59 M | 10.91 M | 9.28 M | ||||||||||
| Low Estimate | 1.51 M | 939,835.87 | 10.57 M | 1.59 M | 1.71 M | 1.56 M | 2.97 M | 2.24 M | 2.26 M | 1.99 M | 2.18 M | 2.47 M | 863,707.01 | 1.43 M | 10.25 M | 8.53 M | ||||||||||
| Consensus Estimate | 1.65 M | 1.04 M | 11.14 M | 1.67 M | 1.81 M | 1.69 M | 3.29 M | 2.47 M | 2.43 M | 2.16 M | 2.26 M | 2.71 M | 950,214.54 | 1.51 M | 10.58 M | 8.91 M |
Analysts expect X4 Pharmaceuticals, Inc to report earnings per share of -0.17 for Q3 26, against a range of -0.18 to -0.16. The most recent reported quarter, Q2 26, came in at -0.13, a 31.6% beat against the -0.19 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -5.40 | -6.00 | 0.04 | -3.47 | -0.69 | -0.22 | -0.16 | -0.13 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -5.06 | -5.23 | -3.54 | -3.86 | -0.49 | -0.25 | -0.18 | -0.18 | -0.16 | -0.18 | -0.18 | -0.16 | 0.95 | 0.85 | -0.35 | -1.08 | ||||||||||
| Low Estimate | -5.50 | -6.05 | -4.00 | -4.58 | -0.57 | -0.27 | -0.20 | -0.20 | -0.18 | -0.22 | -0.20 | -0.18 | 0.83 | 0.73 | -0.41 | -1.26 | ||||||||||
| Consensus Estimate | -5.28 | -5.64 | -3.77 | -4.22 | -0.53 | -0.26 | -0.19 | -0.19 | -0.17 | -0.20 | -0.19 | -0.17 | 0.89 | 0.79 | -0.38 | -1.17 |
Pull Wall Street consensus for X4 Pharmaceuticals, Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=XFOR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "XFOR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=XFOR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();